A traditional Chinese medicine JiuHuangLian (Rhizoma coptidis steamed with rice wine) reduces oxidative stress injury in type 2 diabetic rats

Food and Chemical Toxicology

Volumn 59, Issue , 2013, Pages 222-229

  Li, Jia Chuan ^a,b   Shen, Xiao Fei ^b   Meng, Xian Li ^b  

^a SOUTHWEST UNIVERSITY FOR NATIONALITIES   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cell function; Antioxidation; Diabetes; JiuHuangLian (JHL, Rhizoma Coptidis steamed with rice wine); Oxidative stress; Protection

Indexed keywords

ACYLGLYCEROL; CASPASE 3; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTATHIONE; GLYCOSYLATED HEMOGLOBIN; HERBACEOUS AGENT; INSULIN; JIUHUANGLIAN; MALONALDEHYDE; METFORMIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CHINESE MEDICINE; COPTIS CHINENSIS; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT;

Β-CELL FUNCTION; ANTIOXIDATION; DIABETES; JIUHUANGLIAN (JHL, RHIZOMA COPTIDIS STEAMED WITH RICE WINE); OXIDATIVE STRESS; PROTECTION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; FEMALE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; MALE; ORYZA SATIVA; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEEDS; WINE;

EID: 84880095734     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.06.005     Document Type: Article

References (34)

1. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
2. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
3. Chan J.C., Malik V., Jia W.P., Kadowaki T., Yajnik C., Yoon K.H., Hu F.B. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301:2129-2140.
4. Chen Q., Vazquez E.J., Moghadda S., Hoppe C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria central role of complex III. J. Biol. Chem. 2003, 19:36027-36031.
5. Cherng J., Shih M. Improving glycogenesis in streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci. 2006, 78:1181-1186.
6. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes. Diabetes 2005, 54:S97-S105.
7. Courteix C., Eschalier A., Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 1993, 53:81-88.
8. Davì G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid. Redox Signal. 2005, 7:256-268.
9. Goldstein B., Mahadev K., Wu X.D. Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54:311-318.
10. Grattagliano I., Palmieri V.O., Portincasa P., Moschetta A., Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J. Nutr. Biochem. 2008, 19:491-504.
11. Hall P.M., Cook J.G., Sheldon J., Rutherford S.M., Gould B.J. Glycosylated hemoglobin and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care 1984, 7:147-150.
12. Henningsson R., Salehi A., Lundquist I. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release. Am. J. Physiol., Cell Physiol. 2002, 283:296-304.
13. Kahn S.E. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am. J. Med. 2000, 108:2-8.
14. Kiec A.D., Mykkanen O., Wilk B.K., Mykkanen H. Antioxidant phytochemicals against type 2 diabetes. Br. J. Nutr. 2008, 99:ES109-ES117.
15. Li W.L., Zheng H.C., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 2004, 92:1-21.
16. Li S.P., Zhang G.H., Zeng Q., Huang Z.G., Wang Y.T., Dong T.T.X., Tsim K.W.K. Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine 2006, 13:428-433.
17. Li J.C., Meng X.L., Fan X.J., Lai X.R., Zhang Y., Zeng Y. Pharmacodynamic material basis of Rhizoma Coptidis on insulin resistance. Zhongguo Zhong Yao Za Zhi 2010, 14:1855-1858.
18. Li J.C., Meng X.L., Lai X.R., Fan X.J., Zeng Y., Zhou X.L. Comparative "Zhi xiaoke" efficacy of different processed products of Rhizoma Coptidis in 3T3-L1 cells. Pharmacol. Clin. Chin. Mater. Med. 2010, 26:52-54.
19. Luo Q., Cai Y.Z., Yan J., Sun M., Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004, 76:137-149.
20. Mari A., Schmitz O., Gastaldelli A., Oestergaard T., Nyholm B., Ferrannini E. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E1159-E1166.
21. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
22. McGarry J.D. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51:7-18.
23. Mehl T.D., Wenzel S.E., Russell B., Gardner D., Merimee T.J. Comparison of two indices of glycemic control in diabetic subjects: glycosylated serum protein and hemoglobin. Diabetes Care 1983, 6:34-39.
24. Palsamy P., Sivakumar S., Subramanian S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem. Biol. Interact. 2010, 186:200-210.
25. Poulsen T.M. Apoptotic signal transduction pathways in diabetes. Biochem. Pharmacol. 2003, 66:1433-1440.
26. Robertson R.P., Harmon J., Tran P.O., Poitout V. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004, 53:119-124.
27. Siege K., Narayan K.V. The unite for diabetes campaign: overcoming constraints to find a global policy solution. Glob. Health 2008, 4:1-8.
28. Stumvoll M., Goldstein B.J., Van Haeften T. Pathogenesis of type 2 diabetes. Endocr. Res. 2007, 32:19-37.
29. Subauste A.R., Burant C.F. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 293:159-164.
30. Thulesen J., Orskov C., Holst J.J., Poulsen S.S. Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology 1997, 138:62-68.
31. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742.
32. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
33. Valkoa M., Leibfritzb D., Moncola J., Croninc M., Milan Mazura M., Telserd J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-48.
34. Wautier M.P., Chappey O., Corda S., Stern D., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280:685-694.